Efforts in addressing type 2 diabetes have primarily revolved around enhancing insulin sensitivity, boosting insulin secretion, and impeding or lowering the speed at which glucose is absorbed from the gastrointestinal tract through the means of exercise and dietary approaches aimed at managing obesity [8]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.